Anyone who gets Covid19-related pneumonia will generally be treated with an iv immunoglobulin (Ig) infusion. This is CSL's main product line, accounting for more than 40% of revenue.
Anyone who gets Covid19-related pneumonia will generally be...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$295.79 |
Change
0.790(0.27%) |
Mkt cap ! $142.5B | |||
| Open | High | Low | Value | Volume |
| $295.01 | $295.98 | $293.51 | $30.37M | 102.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 18 | $295.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $295.81 | 3 | 1 |
View Market Depth
| Last trade - 12.16pm 10/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |